Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,182 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05663151Recruiting
Testing how prolonged exposure helps veterans with PTSD
This study looks at why a therapy called prolonged exposure (PE) helps people with PTSD. It includes veterans who want to start PE and checks certain safety and health factors to make sure PE can be used safely.
Boston, MassachusettsAges 18–90 - NCT07215572Recruiting
Group physical therapy for veterans with knee osteoarthritis
This trial studies whether a group physical therapy program can help veterans with knee osteoarthritis. It aims to see if this approach is practical and effective for improving knee pain and function.
Durham, North CarolinaAges Any age - NCT07216261Recruiting
The SWELL study: CBT for insomnia in older veterans
This trial tests whether providing cognitive behavioral therapy for insomnia (CBTI) can help older veterans in VA clinics. CBTI is a non-medication treatment that addresses the thoughts and behaviors that keep you awake.
Durham, North CarolinaAges 60 years+ - NCT06183268Recruiting
Proton therapy for head and neck cancer skin side effects
This study looks at how proton therapy affects skin in people with head and neck cancer. It aims to better understand and manage skin reactions during treatment.
Knoxville, TennesseeAges 18 years+ - NCT06156579RecruitingPhase 2
Venetoclax and Decitabine for Relapsed or Refractory AML
This trial tests a combination of two drugs, venetoclax (a pill) and decitabine (given by IV), for people with AML that has not responded to initial treatment or has come back. The goal is to see if this combination can help control the leukemia again.
Tübingen, Baden-WurttembergAges 18 years+ - NCT07213830RecruitingPhase 1/Phase 2
Study of IPN01203 for advanced solid tumors after immunotherapy
This trial tests an experimental drug called IPN01203 for people with advanced solid tumors that have grown after prior immunotherapy. The goal is to see if the drug is safe and can shrink tumors.
Grand Rapids, MichiganAges 18 years+ - NCT07220915RecruitingPhase 3
Study of Panzyga to prevent infections in people with weak immune systems
This trial tests if a medication called Panzyga can help prevent infections in people with autoimmune conditions who have low antibody levels after B-cell therapy. It may be an option if you have a condition like multiple sclerosis, rheumatoid arthritis, or lupus.
Glendale, ArizonaAges 18 years+ - NCT07214532Recruiting
Using a blood test to guide breast cancer therapy
This study tests whether a blood test can help decide when to start additional hormone-blocking therapy for early-stage breast cancer. It aims to see if starting therapy only when the test detects cancer DNA is as effective as giving it to everyone.
Phoenix, ArizonaAges 18 years+ - NCT07218926RecruitingPhase 3
New drug vs sunitinib for GIST after imatinib
This trial compares a new oral drug, IDRX-42, with the standard drug sunitinib (Sutent) for people with advanced GIST whose cancer has progressed after imatinib therapy. The goal is to see if IDRX-42 can better control the tumor growth.
Phoenix, ArizonaAges 18 years+ - NCT07215273RecruitingPhase 2
Testing a new antifungal for mold infections in immunocompromised people
This study tests a new antifungal drug (EL219) compared to two standard treatments (liposomal amphotericin B or voriconazole) for people with weakened immune systems who have a suspected or confirmed mold infection. The goal is to see if the new drug works as well or better at treating the infection.
Birmingham, AlabamaAges 18 years+ - NCT07212660Recruiting
Comparing two curing methods for fillings in baby teeth
This trial tests two different ways of hardening (curing) the material used for fillings in baby molars. It aims to see which method works better and is safer for children needing fillings for cavities or other damage.
Herzogenbuchsee, Canton of BernAges 4–9 - NCT07215585RecruitingPhase 3
New targeted therapy for elderly or unfit lymphoma patients
This trial tests a new targeted therapy (AZD0486) as a first treatment for older or less fit people with large B-cell lymphoma. It is for those who cannot tolerate the usual strong chemo, aiming to be gentler while still fighting the cancer.
ClaytonAges 65–130 - NCT07219940RecruitingPhase 1
Study of exosome therapy in healthy volunteers
This trial is testing a new medicine made from tiny particles called exosomes that target a protein called HLA-G. The study is being done in healthy people to check if the medicine is safe and how the body handles it.
Baltimore, MarylandAges 18 years+ - NCT06916260Recruiting
Light therapy study for people with Parkinson's disease
This study tests whether light therapy can help people with Parkinson's disease. Participants will receive light therapy sessions and have their symptoms checked before, after, and three months later.
Newark, DelawareAges 50–80 - NCT07218471Recruiting
Cannabis reduction study for heavy users
This study tests if helping people reduce heavy cannabis use improves daily life. It's for adults with cannabis use disorder who want to cut back.
Charleston, South CarolinaAges 18 years+ - NCT07218055Recruiting
Music for mood in children with depression
This study looks at how listening to or making music might help children with depression. Your child would answer questions or keep a diary about their mood and music experiences.
New York, New YorkAges 7–15 - NCT07212335RecruitingEarly Phase 1
Stem cells for low blood counts after CAR-T
This trial tests if umbilical cord stem cells can help restore low blood counts in people with leukemia, lymphoma, or myeloma who still have low blood cell levels three weeks after CAR-T therapy. It aims to improve recovery and reduce infection or bleeding risks.
TianjinAges 18 years+ - NCT07212673Recruiting
Online therapy for binge eating disorder
This study tests a digital program that combines cognitive-behavioral therapy with mindfulness training to help people with binge eating disorder. It may help reduce binge eating episodes and improve your relationship with food.
The Bronx, New YorkAges 18–70 - NCT07214818RecruitingPhase 2/Phase 3
SGLT2 Inhibitors for Adult Primary Nephrotic Syndrome
This trial tests whether SGLT2 inhibitors (a type of diabetes medicine) can help adults with primary nephrotic syndrome, a kidney disease that causes protein leakage and swelling. It aims to see if the drug can protect kidney function and reduce protein loss.
Al Mansurah, Dakahlia GovernorateAges 18 years+ - NCT07212595RecruitingPhase 2
Amino acid therapy to protect kidneys after heart surgery in children
This trial is testing whether giving amino acids after heart surgery can help prevent kidney injury in children at high risk. If it works, it could offer a simple way to protect kidney function during recovery.
Cincinnati, OhioAges Up to 18 years - NCT07217821Recruiting
Music and imagery for chronic pain
This study tests a step-by-step approach using music and guided imagery to help people with long-term muscle or joint pain. It's done from home using a device, so you don't need to travel.
Indianapolis, IndianaAges 18 years+ - NCT07218965Recruiting
Farm family connection study for lonely adults
This study tests if a program that helps build strong relationships can reduce loneliness in adults living in farming areas. You might be eligible if you feel lonely and live in an agricultural community.
Columbus, OhioAges 18 years+ - NCT07216495Recruiting
Exercise study for early-stage triple-negative breast cancer patients
This study tests if aerobic exercise can help women and men with stage 2 or 3 triple-negative breast cancer who are getting chemotherapy and immunotherapy before surgery. It aims to see if exercise improves treatment outcomes and quality of life.
Houston, TexasAges 18 years+ - NCT07220421Recruiting
Stress relief for clinicians: breath and meditation study
This study tests simple breathing and meditation exercises (done daily for 4 weeks) to see if they help reduce stress in clinicians. You'll wear an Oura ring to track your sleep and activity. It's a way to find easy, low-effort tools that fit into a busy life.
Boston, MassachusettsAges 25–70
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,182 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.